Tricuspid valve disease and cardiac implantable electronic devices.
Eur Heart J
; 45(5): 346-365, 2024 Feb 01.
Article
in En
| MEDLINE
| ID: mdl-38096587
ABSTRACT
The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pacemaker, Artificial
/
Rheumatic Heart Disease
/
Tricuspid Valve Insufficiency
/
Defibrillators, Implantable
Limits:
Humans
Language:
En
Journal:
Eur Heart J
Year:
2024
Type:
Article
Affiliation country:
Austria